218 related articles for article (PubMed ID: 7867568)
21. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
22. Effect of hormones and development on the expression of the rat 1,25-dihydroxyvitamin D3 receptor gene. Comparison with calbindin gene expression.
Huang YC; Lee S; Stolz R; Gabrielides C; Pansini-Porta A; Bruns ME; Bruns DE; Miffin TE; Pike JW; Christakos S
J Biol Chem; 1989 Oct; 264(29):17454-61. PubMed ID: 2551904
[TBL] [Abstract][Full Text] [Related]
23. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
25. Variable in vivo regulation of rat vitamin D-dependent genes (osteopontin, Ca,Mg-adenosine triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): implications for differing mechanisms of regulation and involvement of multiple factors.
Matkovits T; Christakos S
Endocrinology; 1995 Sep; 136(9):3971-82. PubMed ID: 7649106
[TBL] [Abstract][Full Text] [Related]
26. Increased vitamin D receptor level enhances 1,25-dihydroxyvitamin D3-mediated gene expression and calcium transport in Caco-2 cells.
Shao A; Wood RJ; Fleet JC
J Bone Miner Res; 2001 Apr; 16(4):615-24. PubMed ID: 11315989
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D-independent expression of chick brain calbindin-D28K.
Hall AK; Norman AW
Brain Res Mol Brain Res; 1991 Jan; 9(1-2):9-14. PubMed ID: 1850081
[TBL] [Abstract][Full Text] [Related]
28. Molecular aspects of the calbindins.
Christakos S; Gill R; Lee S; Li H
J Nutr; 1992 Mar; 122(3 Suppl):678-82. PubMed ID: 1542030
[TBL] [Abstract][Full Text] [Related]
29. Expression of calbindin-D28K mRNA as a function of altered serum calcium and phosphorus levels in vitamin D-replete chick intestine.
Theofan G; King MW; Hall AK; Norman AW
Mol Cell Endocrinol; 1987 Dec; 54(2-3):135-40. PubMed ID: 3691957
[TBL] [Abstract][Full Text] [Related]
30. Modulation of rat calbindin-D28 gene expression by 1,25-dihydroxyvitamin D3 and dietary alteration.
Huang YC; Christakos S
Mol Endocrinol; 1988 Oct; 2(10):928-35. PubMed ID: 2460748
[TBL] [Abstract][Full Text] [Related]
31. Regulation of calbindin-D28K gene expression by 1,25-dihydroxyvitamin D3 in chick kidney.
Hall AK; Norman AW
J Bone Miner Res; 1990 Apr; 5(4):325-30. PubMed ID: 1693034
[TBL] [Abstract][Full Text] [Related]
32. Dietary restriction of calcium, phosphorus, and vitamin D elicits differential regulation of the mRNAs for avian intestinal calbindin-D28k and the 1,25-dihydroxyvitamin D3 receptor.
Meyer J; Fullmer CS; Wasserman RH; Komm BS; Haussler MR
J Bone Miner Res; 1992 Apr; 7(4):441-8. PubMed ID: 1376958
[TBL] [Abstract][Full Text] [Related]
33. Effect of vitamin D metabolites and analogs on renal and intestinal calbindin-D in the rat.
Hemmingsen C; Staun M; Lewin E; Nielsen PK; Olgaard K
Calcif Tissue Int; 1996 Nov; 59(5):371-6. PubMed ID: 8849404
[TBL] [Abstract][Full Text] [Related]
34. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
Farach-Carson MC; Sergeev I; Norman AW
Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
[TBL] [Abstract][Full Text] [Related]
35. Age-related alterations in calbindin-D28K induction by 1,25-dihydroxyvitamin D3 in primary cultures of rat renal tubule cells.
Chen ML; Boltz M; Christakos S; Armbrecht HJ
Endocrinology; 1992 Jun; 130(6):3295-300. PubMed ID: 1597142
[TBL] [Abstract][Full Text] [Related]
36. Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25-dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3.
Nemere I
Endocrinology; 1996 Jun; 137(6):2254-61. PubMed ID: 8641173
[TBL] [Abstract][Full Text] [Related]
37. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
Lee S; Clark SA; Gill RK; Christakos S
Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
[TBL] [Abstract][Full Text] [Related]
38. Modulation of chick intestinal and renal calbindin gene expression by dietary vitamin D3, 1,25-dihydroxyvitamin D3, calcium and phosphorus.
Bar A; Shani M; Fullmer CS; Brindak ME; Striem S
Mol Cell Endocrinol; 1990 Jul; 72(1):23-31. PubMed ID: 2177015
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of calbindin-D28K mRNA in the intestine and eggshell gland of the laying hen.
Bar A; Striem S; Mayel-Afshar S; Lawson DE
J Mol Endocrinol; 1990 Apr; 4(2):93-9. PubMed ID: 2344392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
